Song, L., Bekdash, R., Morikawa, K., Quejada, J. R., Klein, A. D., Aina-Badejo, D., Yoshida, K., Yamamoto, H. E., Chalan, A., Yang, R., Patel, A., Sirabella, D., Lee, T. M., Joseph, L. C., Kawano, F., Warren, J. S., Soni, R. K., Morrow, J. P., & Yazawa, M. (2022). Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome. Nature Cardiovascular Research, 1(2), 142–156. https://doi.org/10.1038/s44161-021-00016-2